Exploring how microbes create important natural products
Structural Studies of Nonribosomal Peptide Synthesis
This study is looking at how tiny microbes make special substances that help them thrive in tough conditions, with the hope of finding new medicines to treat infections and other health issues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Buffalo NIH-funded |
| Lab location | 1 site (Amherst, United States) |
| Project ID | NIH-10804699 on NIH RePORTER |
What this research studies
This research investigates how certain microbes produce natural products that help them survive in challenging environments. By studying the biosynthesis of these unique molecules, the research aims to uncover new pharmaceuticals that could be derived from them. The focus is on nonribosomal peptide synthetases (NRPSs), which are responsible for creating various peptide-based antibiotics and other biologically active compounds. Understanding these processes may lead to the discovery of new drugs that can treat infections and other conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections that may be treated with novel antibiotics derived from microbial natural products.
Not a fit: Patients with conditions that do not involve bacterial infections or require antibiotic treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new antibiotics and other therapeutic agents that are crucial for treating infections and diseases.
How similar studies have performed: Previous research has successfully identified new antibiotics from microbial natural products, indicating that this approach has potential for significant breakthroughs.
Where this research is happening
Amherst, United States
- State University of New York at Buffalo — Amherst, United States (Active)
Researchers
- Principal investigator: Gulick, Andrew M — State University of New York at Buffalo
- Study coordinator: Gulick, Andrew M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.